ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3241

Do Boosters Support Long-Term Physical Activity Maintenance after an Intervention? a Systematic Review

Kathryn Remmes Martin1, Chloé Charlotte Schröder1,2 and Daniel Whibley1, 1Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, 2Faculty For Human and Health Sciences, University of Bremen, Bremen, Germany

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Intervention and physical activity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 11, 2015

Title: ARHP V: Physical Activity

Session Type: ARHP Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: Physical activity (PA) is an important health behaviour, particularly for individuals with rheumatic and musculoskeletal disease (RMD). While PA interventions can successfully increase PA levels, they often reduce over time post-intervention. One strategy for supporting PA maintenance is the introduction of a booster after an initial intervention, though this is less studied. This current review aims to identify whether evidence exists that supports the efficacy of booster components to support PA maintenance.

Methods: A systematic review was undertaken and used a search strategy designed to broadly detect articles focused on PA interventions and long-term maintenance. Eligibility criteria: randomized control trials including healthy community dwelling adults or those with RMD aged 25 years or older. Trials had to include a PA intervention at baseline for all subjects with subsequent randomization to either a booster or non-booster arm, and a PA outcome measure. Cohorts comprised exclusively of non-RMD clinically defined populations (e.g., cancer, diabetes) were excluded. Six electronic bibliographic databases were searched, including Medline and Cochrane Library, with no date restrictions (date of last search December 2014). Study quality and risk of bias were assessed in accordance with the Scottish Intercollegiate Guidelines Network. All stages were independently undertaken by reviewer pairs and consensus was reached after discussion for any discrepancy. A narrative synthesis of results was undertaken.

Results: 16,664 unique studies were identified. After screening by journal, title and abstract, 47 full-text articles were assessed for eligibility, with eight included in the final synthesis. Of these, two were in the workplace, three focused on older adults, and one consisted of individuals with lower-extremity OA. Study duration ranged from 2 to 18 months and employed diverse PA outcome measures, including self-report questionnaires and/or objective markers (e.g., accelerometry). PA interventions included website, mail, in-person counselling, and exercise training sessions. Booster components included mail, email, telephone counselling calls. No identified studies reported significant differences between PA levels between booster and non-booster groups at long-term follow-up. Issues of low sample size/power and sources of bias found in quality assessment suggest definitive conclusions cannot be made.

Conclusion: A limited number of studies have compared boosters to a control group after a cohort has received the same PA intervention. There is a particular paucity of research focused on those with RMD and what is available is heterogeneous and of questionable quality. Evidence strongly supports PA as beneficial to those with RMD, however further research is required to elucidate the role of boosters in the role of supporting long-term maintenance. Attention should be given to the development and rigorous testing of boosters following intervention to support long-term maintenance of PA in RMD populations for sustained health and symptom benefit.


Disclosure: K. R. Martin, None; C. C. Schröder, None; D. Whibley, None.

To cite this abstract in AMA style:

Martin KR, Schröder CC, Whibley D. Do Boosters Support Long-Term Physical Activity Maintenance after an Intervention? a Systematic Review [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/do-boosters-support-long-term-physical-activity-maintenance-after-an-intervention-a-systematic-review/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/do-boosters-support-long-term-physical-activity-maintenance-after-an-intervention-a-systematic-review/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology